Literature DB >> 2199450

Physicochemical properties of the lipopolysaccharide unit that activates B lymphocytes.

K Takayama1, Z Z Din, P Mukerjee, P H Cooke, T N Kirkland.   

Abstract

We have examined the physical state of highly purified deep rough chemotype lipopolysaccharide (ReLPS) from Escherichia coli D31m4 as an aqueous suspension and as complexes with bovine serum albumin min (BSA). The ReLPS suspension showed large ellipsoidal particles 12-38 nm wide and 40-100 nm long. The solubility of this form of ReLPS was determined by equilibrium dialysis experiments to be 3.3 x 10(-8) M at 22 degrees C and 2.8 x 10(-8) M at 37 degrees C in 150 mM Tris-KCl, pH 7.5; 3.0 x 10(-8) M at 37 degrees C in 0.75 mM Tris-KCl, pH 7.5. The BSA-ReLPS complexes were fractionated on a Sephacryl S-200 column to yield peaks I and II with apparent masses of about 240 and 70 kDa, respectively. Peak II was a BSA monomer with estimated BSA:ReLPS molar ratios of 1:1-1:7. The ReLPS suspension and the two complexes were compared as antigens in enzyme-linked immunosorbent assays using three select monoclonal antibodies to lipopolysaccharide. The results were consistent with the high state of disaggregation of the ReLPS in both peaks I and II. Since the ReLPS in these complexes were not visible by electron microscopy, they did not contain vesicles or large particles. All forms of ReLPS tested were capable of stimulating 70Z/3, a lipopolysaccharide-responsive murine pre-B cell line. However, peak II was consistently more stimulatory at very low concentrations than the other preparations. The maximally stimulatory concentration of ReLPS for 70Z/3 cells was 40 ng/ml (1.6 x 10(-8) M) for peak II and 70 ng/ml (2.8 x 10(-8) M) for the ReLPS suspension. As expected, the above concentrations were at or below the solubility of the ReLPS. These results suggested that the highly disaggregated form of ReLPS (possibly the monomer) is the active unit that stimulates the cellular response in 70Z/3 cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199450

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Molecular dynamics simulations of six different fully hydrated monomeric conformers of Escherichia coli re-lipopolysaccharide in the presence and absence of Ca2+.

Authors:  S Obst; M Kastowsky; H Bradaczek
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

2.  A statistical model for activation of Factor C by binding to LPS aggregates.

Authors:  Y Miyagawa; K Kikuchi; M Tsuchiya; S Adachi
Journal:  Eur Biophys J       Date:  2019-10-19       Impact factor: 1.733

3.  Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling.

Authors:  Matteo Piazza; Miriam Colombo; Ivan Zanoni; Francesca Granucci; Paolo Tortora; Jerrold Weiss; Theresa Gioannini; Davide Prosperi; Francesco Peri
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-09       Impact factor: 15.336

4.  Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties.

Authors:  A Shnyra; K Hultenby; A A Lindberg
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

5.  Lipopolysaccharide-induced IgM production is not suppressed by antigen receptor ligation in B cells from some autoimmune strains of mice.

Authors:  C C Anderson; R Rahimpour; N R Sinclair
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

Review 6.  Multiple roles of TRAF3 signaling in lymphocyte function.

Authors:  Gail A Bishop; Ping Xie
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

7.  A novel fluorescent probe that senses the physical state of lipid bilayers.

Authors:  Hirotaka Sasaki; Stephen H White
Journal:  Biophys J       Date:  2009-06-03       Impact factor: 4.033

8.  Aggregation behavior of an ultra-pure lipopolysaccharide that stimulates TLR-4 receptors.

Authors:  Hirotaka Sasaki; Stephen H White
Journal:  Biophys J       Date:  2008-03-28       Impact factor: 4.033

9.  A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.

Authors:  J E Somerville; L Cassiano; B Bainbridge; M D Cunningham; R P Darveau
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

10.  A lipooligosaccharide-binding site on HepG2 cells similar to the gonococcal opacity-associated surface protein Opa.

Authors:  N Porat; M A Apicella; M S Blake
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.